Codes / ICD10CM / I49.0

I49.0 Ventricular fibrillation and flutter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Ventricular Fibrillation and Flutter
  • ICD-10 Code: I49.0

Summary

Ventricular fibrillation and flutter are life-threatening cardiac arrhythmias characterized by rapid, disorganized electrical activity in the ventricles. This disrupts normal heart contractions, leading to ineffective blood pumping and potential cardiac arrest. The condition requires immediate medical intervention to restore normal rhythm and prevent death.

Causes

Ventricular fibrillation and flutter often result from underlying heart disease, such as myocardial infarction, cardiomyopathy, or myocarditis. Other triggers include electrolyte imbalances (e.g., potassium or magnesium abnormalities), drug toxicity (e.g., antiarrhythmics or stimulants), or electrical shock. In some cases, the cause may be idiopathic (unknown).

Risk Factors

  • Coronary artery disease or prior heart attack
  • Heart failure or cardiomyopathy
  • Electrolyte disturbances (e.g., hypokalemia, hypomagnesemia)
  • Structural heart abnormalities
  • Severe physical stress or trauma
  • Certain medications (e.g., proarrhythmic drugs)
  • Family history of sudden cardiac death

Symptoms

  • Sudden loss of consciousness (syncope)
  • Absence of pulse or breathing
  • Chest pain or discomfort
  • Dizziness or lightheadedness
  • Shortness of breath
  • Fatigue or weakness
  • Palpitations (may be reported before collapse)

Diagnosis

Diagnosis is confirmed through electrocardiogram (ECG) or telemetry, which shows characteristic disorganized ventricular activity. Clinical assessment includes evaluating responsiveness, pulse, and breathing. Additional tests, such as cardiac enzymes or imaging, may identify underlying causes.

Treatment Options

Immediate treatment involves cardiopulmonary resuscitation (CPR) and defibrillation to restore normal rhythm. Antiarrhythmic medications (e.g., amiodarone) may be administered. Long-term management includes addressing underlying conditions, implantable cardioverter-defibrillator (ICD) placement, or catheter ablation.

Prognosis and Follow-Up

Prognosis depends on prompt treatment and underlying health. Survival rates improve with early defibrillation, but outcomes vary based on comorbidities. Follow-up includes cardiac monitoring, medication adjustments, and lifestyle modifications to reduce recurrence risk.

Complications

  • Sudden cardiac death
  • Brain damage from prolonged lack of blood flow
  • Heart failure
  • Recurrent arrhythmias
  • Organ damage due to hypoperfusion

Lifestyle & Prevention

  • Manage underlying heart conditions (e.g., hypertension, diabetes)
  • Avoid excessive alcohol or stimulant use
  • Maintain electrolyte balance through diet or supplements
  • Follow prescribed cardiac rehabilitation programs
  • Use protective measures in high-risk environments (e.g., avoiding electrical hazards)

When to Seek Professional Help

Seek emergency care immediately if symptoms of cardiac arrest occur (e.g., unresponsiveness, no pulse). Follow up with a cardiologist for ongoing management of arrhythmias or risk factors.

Tips for Medical Coders

Document the clinical context, including ECG findings, treatment (e.g., defibrillation), and any underlying causes. Ensure specificity in coding by capturing the arrhythmia type and associated conditions. Verify documentation supports the diagnosis and any related interventions for accurate code assignment.

Book a walkthrough

I49.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.